SGEN Tshuag, PRVB Tshuag Rocket Tom qab Nabbing Takeover Deals

Pfizer (PFE) yuav yuav tus kws kho mob cancer Seagen (SGEN) rau kwv yees li $43 billion as Sanofi (SNY) siv sij hawm dhau Provention Bio (PRVB) rau kwv yees li $ 2.9 billion, cov tuam txhab tshaj tawm hnub Monday. Hauv kev teb, SGEN Tshuag thiab PRVB Tshuag rocketed.

X

Pfizer-Seagen daim ntawv cog lus yuav tsum kaw nyob rau hauv lig 2023 los yog thaum ntxov 2024, thiab muaj nuj nqis Seagen Tshuag ntawm $229 ib feem. Sanofi tau them $ 25 ib feem ntawm PRVB Tshuag. Provention tab tom ua haujlwm rau kev kho mob kom ncua qhov pib mob ntshav qab zib hom 1 hauv cov neeg mob hnub nyoog 8 xyoo thiab laus dua.

Seagen yog tus kws tshaj lij hauv kev tsom mus rau mob qog noj ntshav siv tshuaj tiv thaiv kab mob sib txuas, lossis ADCs. Cov kev kho mob no zoo li torpedoes, ncaj qha tshuaj lom ntawm cov qog los tiv thaiv kev puas tsuaj rau cov ntaub so ntswg nyob ib puag ncig. Xyoo no, Seagen cia siab tias yuav tsim tau $ 2.2 nphom hauv kev muag khoom, loj hlob 12%.

Nyob rau hauv premarket trading ntawm lub Tshuag lag luam hnub no, SGEN Tshuag tau nce 15.9% ze 200. Pfizer khoom poob 1.8% ze 38.70. PRVB Tshuag catapulted 261% nyob ze 24.20 raws li Sanofi Tshuag dipped ib feem nyob ze 47.20.

Ntxiv dua los ua raws.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Biotech, Cov Nyiaj Txiag Nyiaj Txiag Tumble Raws li Tsoom Fwv Teb Chaws cov thawj coj txeeb SVB tso nyiaj

Intercept Tumbles Raws li nws qhov kev sim tshuaj NASH ntsib dua lwm qhov teeb meem

Xav Tau Ntau IBD Insights? Sau npe yuav Peb Ua Luam Podcast!

Cov Khoom Cuam Tshuam Yuav Yooj Yim Thiab Saib Xyuas: IPOs Sab saum toj, Lub Kaus Loj Loj Thiab Cov Me Me, Cov Lus Qhia Loj Hlob

Tau Nyiaj Los Ntawm Txij Lub Sij Hawm Luv Nrog SwingTrader